Page last updated: 2024-08-16

sumatriptan and Recrudescence

sumatriptan has been researched along with Recrudescence in 97 studies

Research

Studies (97)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	59 (60.82)	18.2507
2000's	35 (36.08)	29.6817
2010's	3 (3.09)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Calhoun, AH; Ford, S	1
Ghaderibarmi, F; Tavakkoli, N; Togha, M	1
Tfelt-Hansen, P	1
Charmoussi, S; Doitsini, S; Georgiadis, G; Kodounis, A; Mitsikostas, DD; Thomas, A; Vikelis, M; Xifaras, M; Zaglis, D	1
Cabarrocas, X; Dowson, AJ; Laínez, JM; Massiou, H	1
Lines, CR; McCarroll, KA; Visser, WH	1
Pascual, J	2
Arends, LR; Carpay, JA; Koehler, PJ; Linssen, WH; Tiedink, HG	1
Aloisio, A; Del Bianco, P; Di Monda, V; Fonzari, M; Grazioli, I; Nicolodi, M; Sicuteri, F; Uslenghi, C; Vecchiet, L	1
Clark, DW; Coulter, DM; Passier, JL; van Puijenbroek, EP	1
Balbisi, EA	1
Diener, HC; Gendolla, A	1
Brandes, J; Dodick, D; Elkind, A; Mathew, N; Rodichok, L	1
Loder, EW; Mathew, NT	1
Heywood, J; McCrory, P; Ugoni, A	1
Gupta, VK	1
Bigal, ME; Krymchantowski, AV	1
Katsarava, Z; Rabe, K	1
Fuh, JL; Wang, SJ; Wu, ZA	1
Cerbo, R; Del Bene, E; Ferrari, A; Genco, S; Grazioli, I; Martelletti, P; Nappi, G; Pinessi, L; Sandrini, G; Sarchielli, P; Tamburro, P; Uslenghi, C; Zanchin, G	1
Azimova, IuE; Tabeeva, GR	1
Nakazato, Y; Shimazu, K; Tamura, N	1
McTavish, D; Plosker, GL	1
Alderton, CJ; Cutler, NR; Davis, RL; Ferrari, MD; Paulsgrove, LA; Rapoport, AM; Visser, WH	1
Akpunonu, BE; Asgharnejad, M; Brickman, K; Davis, RL; Federman, DJ; Gilbert, C; Mutgi, AB; Volinsky, FG	1
LaPorta, LD	1
Anderson, BA; Ashford, E; Bates, D; Ferrari, MD; James, MH; Nappi, G; Pilgrim, A	1
Dahlöf, C; Ekbom, K; Persson, L	1
Cady, RK; Crummett, D; Littlejohn, TW; Rubino, J	1
Anaya Ordóñez, S; Matas Hoces, A	1
Bateman, DN	1
Arrowsmith, F; Baskin, S; Rapoport, AM; Sheftell, FD; Siegel, S; Weeks, RE	1
Cady, RK; Dexter, J; Markley, H; Osterhaus, JT; Sargent, JD; Webster, CJ	1
Graf, WD; Riback, PS	1
Le Force, B; Margul, B; Ricalde, O; Saper, J; Winner, P	1
Albano, O; Attolini, E; Bassi, A; Cassiano, MA; Cavazzuti, L; Centonze, V; Polito, BM; Ricchhetti, G; Sabbà, C	1
de Vriend, RH; Ferrari, MD; Jaspers, MW; Visser, WH	1
Dahlöf, CG	1
Christiani, K; Dworschak, M; Göbel, H; Heinze, A; Heuss, D; Lindner, V; Stolze, H	1
Pfaffenrath, V	1
de Vriend, RH; Ferrari, MD; Jaspers, NM; Visser, WH	1
Benson, JM; Book, LS; Zorn, SL	1
Burggraaf, J; Cohen, AF; Ferrari, MD; Fowler, PA; Muller, LM; Schoemaker, RC; Visser, WH	1
Aitchison, WR; Barker, PR; McLaren, GI; Scott, RJ	1
Mathew, NT	1
al Deeb, S; al Kawi, Z; Bohlega, S; Cheung, P; Yaqub, B	1
Cull, RE; Dunbar, A; Price, WH	1
Dahlöf, C	3
Accornero, N; De Marinis, M	1
Carpay, HA; Matthijsse, P; Mulder, PG; Steinbuch, M	1
Kaplan, B; Swain, RA	1
Asgharnejad, M; Baker, CC; DeBussey, S; Elkind, A; Mullican, W; Ryan, R	1
Sawyer, J; Schoenen, J	1
Cunin, G; Pfaffenrath, V; Prendergast, S; Sjonell, G	1
Cady, RC; Jhingran, P; O'Quinn, S; Pait, DG; Ryan, R	1
Ferrari, MD; Frants, RR; MaassenVanDenBrink, A; Ophoff, RA; Saxena, PR; Vergouwe, MN	1
Finkel, AG; Howard, JF; Mann, JD	1
Becker, J; Frizelis, K; Kunkel, RS; Solomon, GD	1
Ashford, EA; Becker, WJ; Dahlof, C; Hassani, H; Peikert, A; Salonen, RJ	1
Adriano, M; Fernandes, D; Krymchantowski, AV	1
Millson, D; Tepper, S	1
Peatfield, RC	1
Deleu, D; Hanssens, Y	1
Diener, HC	1
Göbel, H; Heinze, A; Heinze-Kuhn, K; Lindner, V; Stolze, H	1
Ferrari, MD; Goadsby, PJ; Jackson, NC; Olesen, J; Poole, PH; Senard, JM; Stovner, LJ	1
Logemann, CD; Rankin, LM	1
Ashford, EA; Brautaset, NJ; Hassani, H; Reunanen, M; Saiers, J; Savani, N; Szirmai, I	1
Ashford, EA; Gibbs, M; Hassani, H; Salonen, R	1
Ashford, EA; Dowson, AJ; Flöter, T; Hassani, H; Prendergast, S; Roberts, GW; Szczudlik, A	1
Hering-Hanit, R	1
Chitra, R; Dennish, G; Gallagher, RM; Spierings, EL	1
Diener, HC; Geraud, G; Olesen, J; Pfaffenrath, V; Sweet, R; Tfelt-Hansen, P; Zupping, R	1
Géraud, G; Valette, C	1
Krymchantowski, AV	1
Becker, W; Boswell, D; Crisp, A; Göbel, H; Hauge, T; Mihout, B; Niewold, J; Tørring, J; Winter, P	1
Potrebic, S; Raskin, NH	1
Asgharnejad, M; Austin, R; Laurenza, A; Nett, R; Peykamian, M; Rothner, AD; Winner, P	1
Baudesson, G; Imberty-Campinos, C; Pradalier, A; Vincent, D	1
Benassuti, C; Bussone, G; Cortelli, P; Fabbri, L; Manzoni, GC; Roncolato, M	1
Cady, R; DiSerio, F; Elkind, A; Freitag, FG; Gallagher, RM; Goldstein, J; Klapper, JA; Rapoport, AM; Sadowsky, C; Saper, JR; Smith, TR	1
Gruffyd-Jones, K; Kies, B; Middleton, A; Millson, DS; Mulder, LJ; Røsjø , Ø	1
Blau, JN	1
Lloyd, DK; Pilgrim, AJ	1
Anthony, M; Bladin, PF; Donnan, GA; Goadsby, PJ; Lance, JW; Symington, G; Zagami, AS	1

Reviews

18 review(s) available for sumatriptan and Recrudescence

Article	Year
What can be learned from the history of recurrence in migraine? A comment. The journal of headache and pain, 2009, Volume: 10, Issue:5 Topics: Clinical Trials as Topic; Humans; Migraine Disorders; Recurrence; Sumatriptan; Vasoconstrictor Agents	2009
Rizatriptan: pharmacological differences from sumatriptan and clinical results. Current medical research and opinion, 2001, Volume: 17 Suppl 1 Topics: Administration, Oral; Humans; Migraine Disorders; Patient Satisfaction; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines	2001
Almotriptan: pharmacological differences and clinical results. Current medical research and opinion, 2001, Volume: 17 Suppl 1 Topics: Administration, Oral; Humans; Indoles; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	2001
Frovatriptan succinate, a 5-HT1B/1D receptor agonist for migraine. International journal of clinical practice, 2004, Volume: 58, Issue:7 Topics: Carbazoles; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Menstruation Disturbances; Migraine Disorders; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines	2004
[Treatment and prophylaxis of an acute migraine attack]. MMW Fortschritte der Medizin, 2004, Sep-02, Volume: 146, Issue:35-36 Topics: Acupuncture Therapy; Acute Disease; Administration, Oral; Adrenergic beta-Antagonists; Analgesics; Aspirin; Ergotamines; Humans; Metoprolol; Migraine Disorders; Psychotherapy; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Vasoconstrictor Agents	2004
Evaluating the triptans. The American journal of medicine, 2005, Volume: 118 Suppl 1 Topics: Administration, Oral; Clinical Trials as Topic; Humans; Migraine Disorders; Patient Satisfaction; Primary Health Care; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome	2005
Polytherapy in the preventive and acute treatment of migraine: fundamentals for changing the approach. Expert review of neurotherapeutics, 2006, Volume: 6, Issue:3 Topics: Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Drug Administration Schedule; Drug Therapy, Combination; Humans; Migraine Disorders; Recurrence; Sumatriptan	2006
[Medication-overuse headache]. MMW Fortschritte der Medizin, 2006, Aug-31, Volume: 148, Issue:35-36 Topics: Acute Disease; Analgesics; Analgesics, Non-Narcotic; Chronic Disease; Ergotamine; Female; Headache; Headache Disorders, Secondary; Humans; Male; Migraine Disorders; Prognosis; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Tension-Type Headache; Time Factors; Vasoconstrictor Agents	2006
Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs, 1994, Volume: 47, Issue:4 Topics: Administration, Oral; Animals; Cluster Headache; Humans; Injections, Subcutaneous; Migraine Disorders; Nausea; Recurrence; Sumatriptan; Vasoconstriction	1994
Clinical experiences from Sweden on the use of subcutaneously administered sumatriptan in migraine and cluster headache. Archives of neurology, 1994, Volume: 51, Issue:12 Topics: Cardiovascular Diseases; Central Nervous System Diseases; Cluster Headache; Humans; Injections, Subcutaneous; Migraine Disorders; Placebos; Randomized Controlled Trials as Topic; Recurrence; Sumatriptan	1994
Sumatriptan. Lancet (London, England), 1993, Jan-23, Volume: 341, Issue:8839 Topics: Administration, Oral; Clinical Trials as Topic; Humans; Indoles; Injections, Subcutaneous; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan; Treatment Outcome	1993
Pharmacologic treatment of recurrent pediatric headache. Pediatric annals, 1995, Volume: 24, Issue:9 Topics: Acetaminophen; Adolescent; Adrenal Cortex Hormones; Analgesics; Aspirin; Child; Child, Preschool; Ergotamine; Humans; Methylamines; Metoclopramide; Migraine Disorders; Narcotics; Phenothiazines; Recurrence; Sumatriptan; Sympathomimetics; Vasoconstrictor Agents	1995
Serotonin 1D (5-HT1D) agonists and other agents in acute migraine. Neurologic clinics, 1997, Volume: 15, Issue:1 Topics: Acute Disease; Analgesics, Non-Narcotic; Cluster Headache; Dihydroergotamine; Drug Interactions; Humans; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Vasoconstrictor Agents	1997
Diagnosis, prophylaxis, and treatment of headaches in the athlete. Southern medical journal, 1997, Volume: 90, Issue:9 Topics: Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Chronic Disease; Cluster Headache; Dihydroergotamine; Female; GABA Agents; Headache; Humans; Male; Migraine Disorders; Nortriptyline; Physical Exertion; Psychomotor Performance; Recurrence; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sports; Sumatriptan; Tension-Type Headache; Valproic Acid; Vasodilator Agents; Verapamil	1997
Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents. Acta neurologica Belgica, 1999, Volume: 99, Issue:2 Topics: Acute Disease; Animals; Clinical Trials as Topic; Coronary Circulation; Coronary Vasospasm; Drug Design; Drug Interactions; Humans; Inactivation, Metabolic; Indoles; Meninges; Migraine Disorders; Molecular Structure; Nociceptors; Oxazoles; Oxazolidinones; Piperidines; Propranolol; Pyrrolidines; Randomized Controlled Trials as Topic; Rats; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Recurrence; Serotonin Receptor Agonists; Structure-Activity Relationship; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines; Vasoconstrictor Agents	1999
Newer intranasal migraine medications. American family physician, 2000, Jan-01, Volume: 61, Issue:1 Topics: Administration, Intranasal; Administration, Oral; Analgesics, Non-Narcotic; Clinical Trials as Topic; Dihydroergotamine; Half-Life; Humans; Indoles; Migraine Disorders; Oxazoles; Oxazolidinones; Piperidines; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines	2000
New abortive agents for the treatment of migraine. Advances in internal medicine, 2001, Volume: 46 Topics: Clinical Trials as Topic; Female; Humans; Indoles; Male; Migraine Disorders; Oxazolidinones; Piperidines; Prognosis; Recurrence; Serotonin Receptor Agonists; Severity of Illness Index; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines	2001
[Treatment of cluster headache]. La Revue de medecine interne, 2001, Volume: 22, Issue:2 Topics: Anti-Inflammatory Agents; Calcium Channel Blockers; Chronic Disease; Cluster Headache; Combined Modality Therapy; Ergotamine; Humans; Lithium Chloride; Methysergide; Oxygen Inhalation Therapy; Periodicity; Recurrence; Serotonin Receptor Agonists; Steroids; Sumatriptan; Treatment Outcome; Vasoconstrictor Agents; Verapamil	2001

Trials

46 trial(s) available for sumatriptan and Recrudescence

Article	Year
Double-blind, placebo-controlled, crossover study of early-intervention with sumatriptan 85/naproxen sodium 500 in (truly) episodic migraine: what's neck pain got to do with it? Postgraduate medicine, 2014, Volume: 126, Issue:2 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Linear Models; Male; Migraine Disorders; Naproxen; Neck Pain; Pain Measurement; Recurrence; Sumatriptan; Time Factors; Treatment Outcome	2014
Intravenous Valproate versus Subcutaneous Sumatriptan in Acute Migraine Attack. Acta medica Iranica, 2015, Volume: 53, Issue:10 Topics: Adult; Female; Humans; Male; Middle Aged; Migraine Disorders; Nausea; Recurrence; Sumatriptan; Valproic Acid; Vasoconstrictor Agents; Young Adult	2015
Migraine recurrence is not associated with depressive or anxiety symptoms. Results of a randomized controlled trial. Cephalalgia : an international journal of headache, 2010, Volume: 30, Issue:6 Topics: Adult; Anxiety; Cross-Over Studies; Depression; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Recurrence; Sumatriptan; Vasoconstrictor Agents; Young Adult	2010
Almotriptan is an effective and well-tolerated treatment for migraine pain: results of a randomized, double-blind, placebo-controlled clinical trial. Cephalalgia : an international journal of headache, 2002, Volume: 22, Issue:6 Topics: Administration, Oral; Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Multicenter Studies as Topic; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines	2002
Efficacy of sumatriptan nasal spray in recurrent migrainous headache: an open prospective study. Headache, 2003, Volume: 43, Issue:4 Topics: Administration, Inhalation; Adult; Female; Headache Disorders; Humans; Male; Migraine Disorders; Prospective Studies; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome	2003
Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine versus sumatriptan in acute treatment of multiple migraine attacks: a multicenter, randomized, crossover trial. Headache, 2003, Volume: 43, Issue:8 Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Caffeine; Central Nervous System Stimulants; Cross-Over Studies; Drug Combinations; Female; Humans; Indomethacin; Male; Migraine Disorders; Prochlorperazine; Recurrence; Research Design; Serotonin Receptor Agonists; Sumatriptan; Suppositories; Treatment Outcome	2003
Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study. CNS drugs, 2005, Volume: 19, Issue:2 Topics: Administration, Intranasal; Adolescent; Adult; Aged; Double-Blind Method; Drug Tolerance; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazolidinones; Pain Measurement; Reaction Time; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Treatment Outcome; Tryptamines	2005
Intranasal sumatriptan study with high placebo response in Taiwanese patients with migraine. Journal of the Chinese Medical Association : JCMA, 2007, Volume: 70, Issue:2 Topics: Administration, Intranasal; Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Placebo Effect; Recurrence; Sumatriptan	2007
Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel group, mu International journal of clinical practice, 2007, Volume: 61, Issue:8 Topics: Administration, Oral; Adolescent; Adult; Analgesics; Caffeine; Double-Blind Method; Drug Combinations; Female; Humans; Indomethacin; Male; Middle Aged; Migraine Disorders; Prochlorperazine; Recurrence; Sumatriptan; Treatment Outcome	2007
Oral sumatriptan in preventing headache recurrence after treatment of migraine attacks with subcutaneous sumatriptan. Neurology, 1995, Volume: 45, Issue:8 Topics: Administration, Oral; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Injections, Subcutaneous; Male; Migraine Disorders; Recurrence; Sumatriptan; Time Factors	1995
Subcutaneous sumatriptan for treatment of acute migraine in patients admitted to the emergency department: a multicenter study. Annals of emergency medicine, 1995, Volume: 25, Issue:4 Topics: Acute Disease; Administration, Oral; Adult; Aged; Double-Blind Method; Emergency Service, Hospital; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; Recurrence; Sumatriptan; Time Factors; Treatment Outcome	1995
Oral sumatriptan: effect of a second dose, and incidence and treatment of headache recurrences. Cephalalgia : an international journal of headache, 1994, Volume: 14, Issue:5 Topics: Administration, Oral; Adult; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Migraine Disorders; Recurrence; Sumatriptan	1994
Oral sumatriptan in the treatment of recurrent headache. Archives of family medicine, 1994, Volume: 3, Issue:9 Topics: Administration, Oral; Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; Recurrence; Sumatriptan; Time Factors; Treatment Outcome	1994
[Sumatriptan in the treatment of acute migraine: its role in primary health care]. Atencion primaria, 1994, Apr-30, Volume: 13, Issue:7 Topics: Acute Disease; Administration, Oral; Algorithms; Aspirin; Caffeine; Double-Blind Method; Drug Therapy, Combination; Ergotamine; Humans; Injections, Subcutaneous; Metoclopramide; Migraine Disorders; Recurrence; Sumatriptan	1994
Efficacy of subcutaneous sumatriptan in repeated episodes of migraine. Neurology, 1993, Volume: 43, Issue:7 Topics: Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Indoles; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan; Surveys and Questionnaires; Time Factors	1993
A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine. Archives of neurology, 1996, Volume: 53, Issue:2 Topics: Acute Disease; Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Dihydroergotamine; Double-Blind Method; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; Prospective Studies; Recurrence; Serotonin Receptor Agonists; Sumatriptan	1996
Pharmacokinetic and pharmacodynamic profiles of sumatriptan in migraine patients with headache recurrence or no response. Clinical pharmacology and therapeutics, 1996, Volume: 60, Issue:4 Topics: Adolescent; Adult; Aged; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Migraine Disorders; Recurrence; Sumatriptan; Vasoconstrictor Agents	1996
Oral sumatriptan in the acute treatment of migraine and migraine recurrence in general practice. QJM : monthly journal of the Association of Physicians, 1996, Volume: 89, Issue:8 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Migraine Disorders; Recurrence; Sumatriptan; Vasoconstrictor Agents	1996
The efficacy of subcutaneous sumatriptan in the treatment of recurrence of migraine headache. Journal of neurology, neurosurgery, and psychiatry, 1997, Volume: 62, Issue:5 Topics: Adolescent; Adult; Age of Onset; Aged; Double-Blind Method; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; Placebos; Prospective Studies; Recurrence; Severity of Illness Index; Sumatriptan; Treatment Outcome; Vasoconstrictor Agents	1997
Oral and subcutaneous sumatriptan in the acute treatment of migraine: an open randomized cross-over study. Cephalalgia : an international journal of headache, 1997, Volume: 17, Issue:5 Topics: Administration, Oral; Adult; Cross-Over Studies; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Time Factors	1997
Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies. Neurology, 1997, Volume: 49, Issue:5 Topics: Acute Disease; Administration, Intranasal; Adolescent; Adult; Aged; Disability Evaluation; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Sumatriptan	1997
Zolmitriptan (Zomig, 311C90), a novel dual central and peripheral 5HT1B/1D agonist: an overview of efficacy. Cephalalgia : an international journal of headache, 1997, Volume: 17 Suppl 18 Topics: Adolescent; Adult; Aged; Child; Dose-Response Relationship, Drug; Female; Humans; Menstruation; Middle Aged; Migraine Disorders; Nausea; Oxazoles; Oxazolidinones; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines	1997
Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of migraine: defining the optimum doses of oral sumatriptan. Headache, 1998, Volume: 38, Issue:3 Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Sumatriptan	1998
Sumatriptan injection reduces productivity loss during a migraine attack: results of a double-blind, placebo-controlled trial. Archives of internal medicine, 1998, May-11, Volume: 158, Issue:9 Topics: Adult; Double-Blind Method; Efficiency; Female; Humans; Male; Migraine Disorders; Recurrence; Self Administration; Severity of Illness Index; Sumatriptan; Treatment Outcome; Vasoconstrictor Agents; Work	1998
Sumatriptan nasal spray: a dose-ranging study in the acute treatment of migraine. European journal of neurology, 1999, Volume: 6, Issue:1 Topics: Adult; Aerosols; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart; Humans; Hyperacusis; Male; Middle Aged; Migraine Disorders; Nausea; Patient Satisfaction; Photophobia; Recurrence; Salvage Therapy; Sumatriptan; Vasoconstrictor Agents; Vomiting	1999
Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. The ASASUMAMIG St Cephalalgia : an international journal of headache, 1999, Volume: 19, Issue:6 Topics: Adult; Analgesics; Aspirin; Double-Blind Method; Female; Humans; Infusions, Intravenous; Injections, Subcutaneous; Lysine; Male; Middle Aged; Migraine Disorders; Recurrence; Sumatriptan; Treatment Outcome; Vasoconstrictor Agents	1999
Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee. Neurology, 2000, Jan-11, Volume: 54, Issue:1 Topics: Acute Disease; Administration, Oral; Adult; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Placebos; Pyrrolidines; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines; Vasoconstrictor Agents	2000
A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group. International journal of clinical practice. Supplement, 1999, Volume: 105 Topics: Acute Disease; Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Vasoconstrictor Agents	1999
Patient preference for oral sumatriptan 25 mg, 50 mg, or 100 mg in the acute treatment of migraine: a double-blind, randomized, crossover study. Sumatriptan Tablets S2CM11 Study Group. International journal of clinical practice. Supplement, 1999, Volume: 105 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Vasoconstrictor Agents	1999
A comparative trial of zolmitriptan and sumatriptan for the acute oral treatment of migraine. Headache, 2000, Volume: 40, Issue:2 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Patient Satisfaction; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Treatment Outcome; Tryptamines	2000
Comparison of the efficacy of zolmitriptan and sumatriptan: issues in migraine trial design. Cephalalgia : an international journal of headache, 2000, Volume: 20, Issue:1 Topics: Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Recurrence; Research Design; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines	2000
[Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients]. Revue neurologique, 2000, Volume: 156, Issue:6-7 Topics: Administration, Intranasal; Adolescent; Adult; Aged; Female; Humans; Male; Middle Aged; Migraine Disorders; Nausea; Quality of Life; Recurrence; Serotonin Receptor Agonists; Severity of Illness Index; Sumatriptan; Surveys and Questionnaires; Treatment Outcome; Vasoconstrictor Agents	2000
Naproxen sodium decreases migraine recurrence when administered with sumatriptan. Arquivos de neuro-psiquiatria, 2000, Volume: 58, Issue:2B Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Migraine Disorders; Naproxen; Prospective Studies; Recurrence; Serotonin Receptor Agonists; Sumatriptan	2000
Comparison of naratriptan and sumatriptan in recurrence-prone migraine patients. Naratriptan International Recurrence Study Group. Clinical therapeutics, 2000, Volume: 22, Issue:8 Topics: Adolescent; Adult; Aged; Cross-Over Studies; Double-Blind Method; Female; Humans; Indoles; Middle Aged; Migraine Disorders; Piperidines; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Tryptamines; Vasoconstrictor Agents	2000
One-year tolerability and efficacy of sumatriptan nasal spray in adolescents with migraine: results of a multicenter, open-label study. Clinical therapeutics, 2000, Volume: 22, Issue:12 Topics: Administration, Intranasal; Adolescent; Child; Dose-Response Relationship, Drug; Female; Humans; Male; Migraine Disorders; Prospective Studies; Recurrence; Sumatriptan	2000
Efficacy and tolerability of sumatriptan in the treatment of multiple migraine attacks. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2000, Volume: 21, Issue:5 Topics: Adolescent; Adult; Aged; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Sumatriptan	2000
Comparative study of a combination of isometheptene mucate, dichloralphenazone with acetaminophen and sumatriptan succinate in the treatment of migraine. Headache, 2001, Volume: 41, Issue:4 Topics: Acetaminophen; Adult; Analgesics; Antipyrine; Capsules; Chloral Hydrate; Double-Blind Method; Drug Combinations; Female; Humans; Hypnotics and Sedatives; Male; Methylamines; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Sumatriptan	2001
Zolmitriptan versus sumatriptan for the acute oral treatment of migraine: a randomized, double-blind, international study. European journal of neurology, 2001, Volume: 8, Issue:3 Topics: Administration, Oral; Adult; Double-Blind Method; Female; Humans; International Cooperation; Male; Middle Aged; Migraine Disorders; Oxazolidinones; Recurrence; Serotonin Receptor Agonists; Severity of Illness Index; Sumatriptan; Treatment Outcome; Tryptamines	2001
A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group. European neurology, 1992, Volume: 32, Issue:3 Topics: Administration, Oral; Adolescent; Adult; Aged; Aspirin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Indoles; Male; Metoclopramide; Middle Aged; Migraine Disorders; Recurrence; Sulfonamides; Sumatriptan; Vasoconstrictor Agents	1992
Sumatriptan and recurrence of migraine. Lancet (London, England), 1992, Oct-31, Volume: 340, Issue:8827 Topics: Double-Blind Method; Drug Administration Schedule; Humans; Indoles; Migraine Disorders; Recurrence; Sulfonamides; Sumatriptan; Vasoconstrictor Agents	1992
Treatment of migraine attacks with sumatriptan. The New England journal of medicine, 1991, 08-01, Volume: 325, Issue:5 Topics: Adolescent; Adult; Aged; Consumer Behavior; Double-Blind Method; Drug Tolerance; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Receptors, Serotonin; Recurrence; Safety; Sulfonamides; Sumatriptan; Vasoconstrictor Agents	1991
Evaluation of a multiple-dose regimen of oral sumatriptan for the acute treatment of migraine. The Oral Sumatriptan International Multiple-Dose Study Group. European neurology, 1991, Volume: 31, Issue:5 Topics: Adult; Aged; Consumer Behavior; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Incidence; Indoles; Male; Middle Aged; Migraine Disorders; Nausea; Recurrence; Sulfonamides; Sumatriptan; Vasoconstrictor Agents; Vomiting	1991
A randomized, double-blind comparison of sumatriptan and Cafergot in the acute treatment of migraine. The Multinational Oral Sumatriptan and Cafergot Comparative Study Group. European neurology, 1991, Volume: 31, Issue:5 Topics: Administration, Oral; Adult; Aged; Caffeine; Double-Blind Method; Drug Combinations; Electrocardiography; Ergotamine; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Nausea; Recurrence; Sulfonamides; Sumatriptan; Vasoconstrictor Agents; Vomiting	1991
Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device. The Sumatriptan Auto-Injector Study Group. European neurology, 1991, Volume: 31, Issue:5 Topics: Adult; Aged; Consumer Behavior; Double-Blind Method; Female; Humans; Indoles; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; Nausea; Recurrence; Self Administration; Sulfonamides; Sumatriptan; Vasoconstrictor Agents; Vomiting	1991
A placebo-controlled study of intranasal sumatriptan for the acute treatment of migraine. The Finnish Sumatriptan Group and the Cardiovascular Clinical Research Group. European neurology, 1991, Volume: 31, Issue:5 Topics: Absorption; Administration, Intranasal; Adult; Disability Evaluation; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Nausea; Recurrence; Sulfonamides; Sumatriptan; Vasoconstrictor Agents; Vomiting	1991
Oral sumatriptan in acute migraine. Lancet (London, England), 1991, Sep-28, Volume: 338, Issue:8770 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Double-Blind Method; Drug Evaluation; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Recurrence; Sulfonamides; Sumatriptan; Vasoconstrictor Agents	1991

Other Studies

33 other study(ies) available for sumatriptan and Recrudescence

Article	Year
Activation of pain by sumatriptan. Headache, 2003, Volume: 43, Issue:9 Topics: Adult; Female; Humans; Inflammation; Injections, Subcutaneous; Male; Middle Aged; Pain; Prospective Studies; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Wounds and Injuries	2003
[Strong and sustained-acting triptan. Therewith migraine does not return soon]. MMW Fortschritte der Medizin, 2003, Aug-07, Volume: 145, Issue:31-32 Topics: Administration, Oral; Clinical Trials as Topic; Humans; Indoles; Migraine Disorders; Placebos; Pyrrolidines; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Tryptamines; Vasoconstrictor Agents	2003
Open label study of intranasal sumatriptan (Imigran) for footballer's headache. British journal of sports medicine, 2005, Volume: 39, Issue:8 Topics: Administration, Intranasal; Headache; Humans; Migraine Disorders; Migraine without Aura; Pain Measurement; Pilot Projects; Recurrence; Severity of Illness Index; Soccer; Sumatriptan; Treatment Outcome; Vasodilator Agents	2005
Change in frequency pattern in cluster headache induced by subcutaneous sumatriptan. Headache, 2005, Volume: 45, Issue:8 Topics: Cluster Headache; Humans; Injections, Subcutaneous; Recurrence; Serotonin Receptor Agonists; Sumatriptan	2005
[Efficacy of sumamigren at early and late stages of migraine attack]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2007, Volume: 107, Issue:8 Topics: Adult; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Migraine Disorders; Pain Measurement; Recurrence; Serotonin Receptor Agonists; Severity of Illness Index; Sumatriptan; Time Factors; Treatment Outcome	2007
An adult case of cyclic vomiting syndrome successfully responding to valproic acid. Journal of neurology, 2008, Volume: 255, Issue:6 Topics: Anti-Anxiety Agents; Anticonvulsants; Antiemetics; Consciousness Disorders; Diazepam; Female; Humans; Middle Aged; Migraine Disorders; Recurrence; Sumatriptan; Syndrome; Valproic Acid; Vascular Headaches; Vasoconstrictor Agents; Vomiting	2008
Recurrent depression after sumatriptan administration for treatment of migraine. Journal of clinical psychopharmacology, 1995, Volume: 15, Issue:1 Topics: Depressive Disorder; Female; Humans; Middle Aged; Migraine Disorders; Recurrence; Sumatriptan	1995
Subcutaneous sumatriptan in a clinical setting: the first 100 consecutive patients with acute migraine in a tertiary care center. Headache, 1994, Volume: 34, Issue:2 Topics: Acute Disease; Adolescent; Adult; Aged; Ambulatory Care Facilities; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; Recurrence; Sumatriptan	1994
Use of high sumatriptan dosages during episodic cluster headache: three clinical cases. Headache, 1996, Volume: 36, Issue:6 Topics: Adult; Cluster Headache; Humans; Injections, Subcutaneous; Male; Middle Aged; Recurrence; Serotonin Receptor Agonists; Sumatriptan	1996
Sumatriptan in clinical practice: a 2-year review of 453 migraine patients. Neurology, 1996, Volume: 47, Issue:1 Topics: Adult; Female; Humans; Male; Middle Aged; Migraine Disorders; Netherlands; Recurrence; Sumatriptan	1996
How does sumatriptan perform in clinical practice? Cephalalgia : an international journal of headache, 1995, Volume: 15 Suppl 15 Topics: Administration, Oral; Adult; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; Recurrence; Sumatriptan; Sweden; Treatment Outcome	1995
[18 months long-term analysis of effectiveness, safety and tolerance of sumatriptan s.c. in acute therapy of migraine attacks]. Der Nervenarzt, 1996, Volume: 67, Issue:6 Topics: Adult; Drug Tolerance; Female; Follow-Up Studies; Humans; Injections, Subcutaneous; Long-Term Care; Male; Middle Aged; Migraine Disorders; Pain Measurement; Prospective Studies; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Vasodilator Agents	1996
Headache recurrence. Cephalalgia : an international journal of headache, 1996, Volume: 16, Issue:4 Topics: Headache; Humans; Recurrence; Sumatriptan	1996
Risk factors for headache recurrence after sumatriptan: a study in 366 migraine patients. Cephalalgia : an international journal of headache, 1996, Volume: 16, Issue:4 Topics: Adult; Female; Headache; Humans; Male; Middle Aged; Prognosis; Recurrence; Risk Factors; Sumatriptan	1996
Sumatriptan in the treatment of cyclic vomiting. The Annals of pharmacotherapy, 1995, Volume: 29, Issue:10 Topics: Abdominal Pain; Adult; Humans; Male; Nausea; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Vomiting	1995
Sumatriptan treatment of acute migraine attacks in a Saudi population. Clinical neurology and neurosurgery, 1997, Volume: 99, Issue:1 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Male; Middle Aged; Migraine Disorders; Prospective Studies; Recurrence; Saudi Arabia; Sumatriptan; Treatment Outcome; Vasoconstrictor Agents	1997
Would any acute treatment for migraine demonstrate recurrence? Cephalalgia : an international journal of headache, 1997, Volume: 17 Suppl 17 Topics: Humans; Migraine Disorders; Oxazoles; Oxazolidinones; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines	1997
Recurrent neck pain as a variant of migraine: description of four cases. Journal of neurology, neurosurgery, and psychiatry, 1997, Volume: 62, Issue:6 Topics: Adult; Carotid Arteries; Female; Humans; Magnetic Resonance Imaging; Migraine Disorders; Neck; Pain; Pupil; Recurrence; Sumatriptan; Vasoconstrictor Agents	1997
5-HT1B receptor polymorphism and clinical response to sumatriptan. Headache, 1998, Volume: 38, Issue:4 Topics: Adult; Aged; Alleles; Female; Gene Frequency; Humans; Male; Middle Aged; Migraine Disorders; Polymorphism, Genetic; Receptors, Serotonin; Recurrence; Serotonin Receptor Agonists; Sumatriptan	1998
Successful treatment of headache related to intravenous immunoglobulin with antimigraine medications. Headache, 1998, Volume: 38, Issue:4 Topics: Adult; Analgesics, Non-Narcotic; Dihydroergotamine; Female; Headache; Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Myasthenia Gravis; Recurrence; Serotonin Receptor Agonists; Sumatriptan	1998
Dosing of oral sumatriptan: a review of our first 104 patients. Headache, 1998, Volume: 38, Issue:5 Topics: Administration, Oral; Dose-Response Relationship, Drug; Humans; Injections, Subcutaneous; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Sumatriptan	1998
Tolfenamic acid decreases migraine recurrence when used with sumatriptan. Cephalalgia : an international journal of headache, 1999, Volume: 19, Issue:3 Topics: Adult; Analgesics; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Migraine Disorders; ortho-Aminobenzoates; Recurrence; Sumatriptan	1999
Issues relating to the assessment of migraine recurrence following triptan therapy. European journal of neurology, 1999, Volume: 6, Issue:4 Topics: Humans; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Sumatriptan	1999
Migraine: which triptan? Hospital medicine (London, England : 1998), 1999, Volume: 60, Issue:4 Topics: Drug Administration Routes; Drug Costs; Family Practice; Humans; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Sumatriptan	1999
Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment. Cephalalgia : an international journal of headache, 1999, Volume: 19, Issue:7 Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Analgesics; Antiemetics; Calcium Channel Blockers; Cohort Studies; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Female; Headache; Humans; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; Patient Dropouts; Prospective Studies; Recurrence; Safety; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Vasoconstrictor Agents	1999
Patient-selected dosing in a six-month open-label study evaluating oral sumatriptan in the acute treatment of migraine. Sumatriptan Tablets S2CM10 Study Group. International journal of clinical practice. Supplement, 1999, Volume: 105 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Analgesia; Female; Humans; Male; Middle Aged; Migraine Disorders; Patient Participation; Patient Satisfaction; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Vasoconstrictor Agents	1999
Alteration in nature of cluster headache during subcutaneous administration of sumatriptan. Headache, 2000, Volume: 40, Issue:1 Topics: Adult; Chronic Disease; Cluster Headache; Headache; Humans; Injections, Subcutaneous; Male; Middle Aged; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Time Factors	2000
Zolmitriptan: new product. Similar to sumatriptan. Prescrire international, 1999, Volume: 8, Issue:40 Topics: Clinical Trials as Topic; Drug Interactions; Humans; Migraine Disorders; Oxazoles; Placebos; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome	1999
Clinical benefits of early triptan therapy for migraine. Headache, 2002, Volume: 42 Suppl 1 Topics: Acute Disease; Dose-Response Relationship, Drug; Early Diagnosis; Humans; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines	2002
Sumatriptan, serotonin, migraine, and money. Lancet (London, England), 1992, Jan-18, Volume: 339, Issue:8786 Topics: Acute Disease; Costs and Cost Analysis; Humans; Indoles; Migraine Disorders; Recurrence; Serotonin; Sulfonamides; Sumatriptan; United Kingdom; Vasoconstrictor Agents	1992
Headache recurrence after subcutaneous sumatriptan. Lancet (London, England), 1992, Feb-15, Volume: 339, Issue:8790 Topics: Adult; Female; Humans; Indoles; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; Recurrence; Sulfonamides; Sumatriptan; Vasoconstrictor Agents	1992
Headache recurrence after subcutaneous sumatriptan and early treatment. Lancet (London, England), 1992, Oct-10, Volume: 340, Issue:8824 Topics: Adult; Female; Headache; Humans; Indoles; Injections, Subcutaneous; Male; Middle Aged; Recurrence; Sulfonamides; Sumatriptan; Vasoconstrictor Agents	1992
Sumatriptan and recurrence of migraine. Lancet (London, England), 1992, Oct-31, Volume: 340, Issue:8827 Topics: Humans; Indoles; Migraine Disorders; Recurrence; Sulfonamides; Sumatriptan; Vasoconstrictor Agents	1992